×
About 271 results

ALLMedicine™ Episcleritis Center

Research & Reviews  131 results

Ocular Manifestations of Inflammatory Bowel Disease.
https://doi.org/10.1093/ibd/izaa359
Inflammatory Bowel Diseases; Shah J, Shah A et. al.

Jan 27th, 2021 - Inflammatory bowel disease (IBD) is characterized by intestinal inflammation; however, it is also known to have extraintestinal manifestations. Ocular manifestations of IBD include keratopathy, episcleritis, scleritis, and uveitis and are among th...

Vedolizumab and Extraintestinal Manifestations in Inflammatory Bowel Disease.
https://doi.org/10.1007/s40265-020-01460-3 10.1097/MIB.0000000000000392 10.1155/2019/5354320 10.1093/ecco-jcc/jjy191 10.1038/nri1784 10.1056/NEJMoa1215734 10.1056/NEJMoa1215739 10.1111/j.1572-0241.2001.03756.x 10.1038/ajg.2010.343 10.1093/ecco-jcc/jjv232 10.1097/MIB.0000000000000429 10.1097/00004836-199607000-00009 10.1093/ecco-jcc/jjv238 10.1097/00005792-197609000-00004 10.1093/ecco-jcc/jjv178 10.1136/gut.42.3.387 10.1002/1529-0131(200112)44:12<2728::AID-ART459>3.0.CO;2-8 10.1111/j.1365-2036.2008.03868.x 10.1016/j.crohns.2010.10.006 10.1097/01.MIB.0000442011.60285.68 10.1016/j.survophthal.2003.08.004 10.14309/ajg.0000000000000268 10.1111/j.1440-1746.2012.07150.x 10.1097/MEG.0000000000000747 10.1002/ibd.20529 10.1016/S0952-7915(00)00096-0 10.1126/science.272.5258.60 10.1016/S0140-6736(14)60661-9 10.1056/NEJMoa020732 10.1586/1744666X.2.5.759 10.1016/j.jaut.2016.01.001 10.1084/jem.20041035 10.1053/jhep.2001.24231 10.1136/annrheumdis-2014-206323 10.4049/jimmunol.166.7.4650 10.1084/jem.181.1.137 10.1084/jem.180.6.2359 10.1016/S0140-6736(95)91089-1 10.1074/jbc.M205470200 10.1016/j.immuni.2015.07.014 10.1016/0016-5085(95)90263-5 10.1016/S0016-5085(98)70310-5 10.1016/0016-5085(90)90839-S 10.1016/0016-5085(94)90066-3 10.1084/jem.20091233 10.1016/j.autrev.2017.02.013 10.1007/s100670070003 10.1155/2001/612531 10.1136/ard.2009.110767 10.1093/ecco-jcc/jjv213 10.1093/ecco-jcc/jjx008 10.1097/00124743-199806000-00007 10.1136/ard.2003.019174 10.1111/j.1572-0241.2006.00384.x 10.1016/j.cgh.2005.12.002 10.1038/nrgastro.2015.208 10.1136/annrheumdis-2016-210770 10.1002/art.1780380507 10.1002/art.1780391209 10.1111/j.1572-0241.2002.06064.x 10.1016/S0140-6736(00)03239-6 10.1136/ard.2003.012450 10.1002/ibd.21663 10.1080/03009740510026698 10.4321/S1130-01082012000900004 10.1136/annrheumdis-2013-204655 10.1016/S0140-6736(13)60594-2 10.1002/art.40728 10.1080/14712598.2020.1830057 10.1136/annrheumdis-2016-210322 10.14309/crj.0000000000000226 10.1016/j.cgh.2018.08.017 10.1097/01.MIB.0000436959.62286.f9 10.1093/ibd/izy174 10.1056/NEJMoa013383 10.1007/s12016-012-8351-x 10.5858/arpa.2010-0666-RS 10.1016/j.clindermatol.2007.10.018 10.1111/j.1365-2230.2006.02221.x 10.1016/j.jaad.2016.06.016 10.1001/archdermatol.2010.393 10.1136/bmj.h2958 10.1136/gut.2005.074815 10.1007/s10620-013-2762-2 10.1111/apt.15766 10.1093/ecco-jcc/jjaa078 10.1016/j.cgh.2018.10.047 10.3748/wjg.v23.i32.5836 10.1002/hep.20466 10.1016/j.ophtha.2013.09.048 10.1056/NEJMoa1509852 10.1093/ecco-jcc/jjz167 10.1097/MCG.0b013e3181662426 10.1111/apt.14829 10.1016/j.cgh.2020.02.014 10.1055/s-0043-107029 10.1093/ecco-jcc/jjy125 10.1016/j.dld.2018.02.013 10.1093/ibd/izy065 10.1093/ibd/izy127 10.1093/rheumatology/keaa107 10.1111/apt.14419 10.1007/s10067-018-4357-y 10.1093/rheumatology/key267 10.1136/annrheumdis-2016-210233 10.1007/s10620-018-4971-1 10.1093/ecco-jcc/jjz088 10.1111/apt.14525 10.1016/j.cgh.2019.05.013 10.1016/j.dld.2010.12.008 10.1002/hep.23082 10.1093/rheumatology/kez056 10.1016/j.autrev.2013.06.005 10.1136/gutjnl-2015-311079 10.1016/j.jhep.2019.05.006 10.1093/ecco-jcc/jjx158 10.1038/ajg.2017.395 10.1136/ard.2009.108233 10.1136/ard.2008.100826 10.1002/hep.28256
Drugs Hanzel J, Ma C et. al.

Jan 5th, 2021 - In Crohn's disease and ulcerative colitis, inflammation is not limited to the digestive tract. Extraintestinal manifestations (EIMs), which affect up to 50% of patients, can substantially impair quality of life. EIMs may parallel luminal disease a...

Propylthiouracil-Induced Anti-Neutrophil Cytoplasmic Antibody Vasculitis Presenting wit...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7733149
The American Journal of Case Reports; Alidoost M, Cheng J et. al.

Dec 9th, 2020 - BACKGROUND Drug-induced anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) should be suspected in patients on certain medications who present with inflammatory ocular, constitutional, pulmonary, and/or renal manifestations. He...

Bilateral Nodular Episcleritis: A Rare Presentation of Relapsing Polychondritis.
https://doi.org/10.1097/IOP.0000000000001849
Ophthalmic Plastic and Reconstructive Surgery; Meel R, Das D et. al.

Oct 16th, 2020 - Herein, the authors report a case of relapsing polychondritis (RP) presenting as isolated bilateral nodular episcleritis. A 23-year-old male presented to us with bilateral large ocular surface masses for which he had received antitubercular medica...

see more →

Clinicaltrials.gov  137 results

Ocular Manifestations of Inflammatory Bowel Disease.
https://doi.org/10.1093/ibd/izaa359
Inflammatory Bowel Diseases; Shah J, Shah A et. al.

Jan 27th, 2021 - Inflammatory bowel disease (IBD) is characterized by intestinal inflammation; however, it is also known to have extraintestinal manifestations. Ocular manifestations of IBD include keratopathy, episcleritis, scleritis, and uveitis and are among th...

Vedolizumab and Extraintestinal Manifestations in Inflammatory Bowel Disease.
https://doi.org/10.1007/s40265-020-01460-3 10.1097/MIB.0000000000000392 10.1155/2019/5354320 10.1093/ecco-jcc/jjy191 10.1038/nri1784 10.1056/NEJMoa1215734 10.1056/NEJMoa1215739 10.1111/j.1572-0241.2001.03756.x 10.1038/ajg.2010.343 10.1093/ecco-jcc/jjv232 10.1097/MIB.0000000000000429 10.1097/00004836-199607000-00009 10.1093/ecco-jcc/jjv238 10.1097/00005792-197609000-00004 10.1093/ecco-jcc/jjv178 10.1136/gut.42.3.387 10.1002/1529-0131(200112)44:12<2728::AID-ART459>3.0.CO;2-8 10.1111/j.1365-2036.2008.03868.x 10.1016/j.crohns.2010.10.006 10.1097/01.MIB.0000442011.60285.68 10.1016/j.survophthal.2003.08.004 10.14309/ajg.0000000000000268 10.1111/j.1440-1746.2012.07150.x 10.1097/MEG.0000000000000747 10.1002/ibd.20529 10.1016/S0952-7915(00)00096-0 10.1126/science.272.5258.60 10.1016/S0140-6736(14)60661-9 10.1056/NEJMoa020732 10.1586/1744666X.2.5.759 10.1016/j.jaut.2016.01.001 10.1084/jem.20041035 10.1053/jhep.2001.24231 10.1136/annrheumdis-2014-206323 10.4049/jimmunol.166.7.4650 10.1084/jem.181.1.137 10.1084/jem.180.6.2359 10.1016/S0140-6736(95)91089-1 10.1074/jbc.M205470200 10.1016/j.immuni.2015.07.014 10.1016/0016-5085(95)90263-5 10.1016/S0016-5085(98)70310-5 10.1016/0016-5085(90)90839-S 10.1016/0016-5085(94)90066-3 10.1084/jem.20091233 10.1016/j.autrev.2017.02.013 10.1007/s100670070003 10.1155/2001/612531 10.1136/ard.2009.110767 10.1093/ecco-jcc/jjv213 10.1093/ecco-jcc/jjx008 10.1097/00124743-199806000-00007 10.1136/ard.2003.019174 10.1111/j.1572-0241.2006.00384.x 10.1016/j.cgh.2005.12.002 10.1038/nrgastro.2015.208 10.1136/annrheumdis-2016-210770 10.1002/art.1780380507 10.1002/art.1780391209 10.1111/j.1572-0241.2002.06064.x 10.1016/S0140-6736(00)03239-6 10.1136/ard.2003.012450 10.1002/ibd.21663 10.1080/03009740510026698 10.4321/S1130-01082012000900004 10.1136/annrheumdis-2013-204655 10.1016/S0140-6736(13)60594-2 10.1002/art.40728 10.1080/14712598.2020.1830057 10.1136/annrheumdis-2016-210322 10.14309/crj.0000000000000226 10.1016/j.cgh.2018.08.017 10.1097/01.MIB.0000436959.62286.f9 10.1093/ibd/izy174 10.1056/NEJMoa013383 10.1007/s12016-012-8351-x 10.5858/arpa.2010-0666-RS 10.1016/j.clindermatol.2007.10.018 10.1111/j.1365-2230.2006.02221.x 10.1016/j.jaad.2016.06.016 10.1001/archdermatol.2010.393 10.1136/bmj.h2958 10.1136/gut.2005.074815 10.1007/s10620-013-2762-2 10.1111/apt.15766 10.1093/ecco-jcc/jjaa078 10.1016/j.cgh.2018.10.047 10.3748/wjg.v23.i32.5836 10.1002/hep.20466 10.1016/j.ophtha.2013.09.048 10.1056/NEJMoa1509852 10.1093/ecco-jcc/jjz167 10.1097/MCG.0b013e3181662426 10.1111/apt.14829 10.1016/j.cgh.2020.02.014 10.1055/s-0043-107029 10.1093/ecco-jcc/jjy125 10.1016/j.dld.2018.02.013 10.1093/ibd/izy065 10.1093/ibd/izy127 10.1093/rheumatology/keaa107 10.1111/apt.14419 10.1007/s10067-018-4357-y 10.1093/rheumatology/key267 10.1136/annrheumdis-2016-210233 10.1007/s10620-018-4971-1 10.1093/ecco-jcc/jjz088 10.1111/apt.14525 10.1016/j.cgh.2019.05.013 10.1016/j.dld.2010.12.008 10.1002/hep.23082 10.1093/rheumatology/kez056 10.1016/j.autrev.2013.06.005 10.1136/gutjnl-2015-311079 10.1016/j.jhep.2019.05.006 10.1093/ecco-jcc/jjx158 10.1038/ajg.2017.395 10.1136/ard.2009.108233 10.1136/ard.2008.100826 10.1002/hep.28256
Drugs Hanzel J, Ma C et. al.

Jan 5th, 2021 - In Crohn's disease and ulcerative colitis, inflammation is not limited to the digestive tract. Extraintestinal manifestations (EIMs), which affect up to 50% of patients, can substantially impair quality of life. EIMs may parallel luminal disease a...

Propylthiouracil-Induced Anti-Neutrophil Cytoplasmic Antibody Vasculitis Presenting wit...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7733149
The American Journal of Case Reports; Alidoost M, Cheng J et. al.

Dec 9th, 2020 - BACKGROUND Drug-induced anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) should be suspected in patients on certain medications who present with inflammatory ocular, constitutional, pulmonary, and/or renal manifestations. He...

Bilateral Nodular Episcleritis: A Rare Presentation of Relapsing Polychondritis.
https://doi.org/10.1097/IOP.0000000000001849
Ophthalmic Plastic and Reconstructive Surgery; Meel R, Das D et. al.

Oct 16th, 2020 - Herein, the authors report a case of relapsing polychondritis (RP) presenting as isolated bilateral nodular episcleritis. A 23-year-old male presented to us with bilateral large ocular surface masses for which he had received antitubercular medica...

see more →

News  3 results

Eye Pain in a Woman With Multiple Health Conditions
https://www.medscape.com/viewarticle/822141_4

Mar 23rd, 2014 - Treatment and Clinical Course Even though episcleritis is self-limited, topical drop intervention is usually the mainstay treatment course for patients who are symptomatic. Topical steroids or topical nonsteroidal anti-inflammatory drugs (NSAIDs) ...

Eye Pain in a Woman With Multiple Health Conditions
https://www.medscape.com/viewarticle/822141_2

Mar 23rd, 2014 - Differential Diagnosis Because of the presentation and symptoms, episcleritis was the most likely diagnosis. Viral conjunctivitis is a possibility, but it typically presents with watery discharge and edematous eyes, and shows signs of follicle as ...

Infectious Scleritis Often Tied to Herpes Virus
https://www.medscape.com/viewarticle/762079

Apr 15th, 2012 - By David Douglas NEW YORK (Reuters Health) Apr 13 - Almost 75% of cases of infectious scleritis result from herpes virus, but the diagnosis is often missed, a new paper warns. Such infection is more common than might be generally thought, said sen...

see more →